Overall Survival with Maintenance Olaparib at a 7-Year Follow-up in Patients with Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

SOLO1 Investigators

doi:10.1097/OGX.0000000000001120

Overall Survival with Maintenance Olaparib at a 7-Year Follow-up in Patients with Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

SOLO1 Investigators

Department of Obstetrics and Gynecology

Women and Infants Hospital of Rhode Island
Royal Marsden NHS Foundation Trust
University of Milan - Bicocca
IRCCS
Vall d'Hebron Institute of Oncology
University of New South Wales
St Petersburg Oncology Dispensary
Centre Georges-François Leclerc
Groupe D'Investigateurs Nationaux pour L'Etude des Cancers Ovariens
Gustave Roussy
Netherlands Cancer Institute
University of Edinburgh
Princess Margaret Cancer Centre
University of Navarra
CIMA
Memorial Sloan-Kettering Cancer Center
Medical College of Wisconsin
Dana-Farber Cancer Institute
AstraZeneca
Stephenson Cancer Center

Research output: Contribution to journal › Comment/debate

9 Scopus citations

Original language	English
Pages (from-to)	25-27
Number of pages	3
Journal	Obstetrical and Gynecological Survey
Volume	78
Issue number	1
DOIs	https://doi.org/10.1097/OGX.0000000000001120
State	Published - 1 Jan 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1097/OGX.0000000000001120

Cite this

@article{130f906784d8459cb205da8cf1559bca,

title = "Overall Survival with Maintenance Olaparib at a 7-Year Follow-up in Patients with Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial",

author = "\{SOLO1 Investigators\} and Paul DiSilvestro and Susana Banerjee and Nicoletta Colombo and Giovanni Scambia and Kim, \{Byoung Gie\} and Ana Oaknin and Michael Friedlander and Alla Lisyanskaya and Anne Floquet and Alexandra Leary and Sonke, \{Gabe S.\} and Charlie Gourley and Amit Oza and Antonio Gonz{\'a}lez-Mart{\'i} and Carol Aghajanian and William Bradley and Cara Mathews and Joyce Liu and John McNamara and Lowe, \{Elizabeth S.\} and Ah-See, \{Mei Lin\} and Moore, \{Kathleen N.\}",

year = "2023",

month = jan,

day = "1",

doi = "10.1097/OGX.0000000000001120",

language = "English",

volume = "78",

pages = "25--27",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Overall Survival with Maintenance Olaparib at a 7-Year Follow-up in Patients with Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation

T2 - The SOLO1/GOG 3004 Trial

AU - SOLO1 Investigators

AU - DiSilvestro, Paul

AU - Banerjee, Susana

AU - Colombo, Nicoletta

AU - Scambia, Giovanni

AU - Kim, Byoung Gie

AU - Oaknin, Ana

AU - Friedlander, Michael

AU - Lisyanskaya, Alla

AU - Floquet, Anne

AU - Leary, Alexandra

AU - Sonke, Gabe S.

AU - Gourley, Charlie

AU - Oza, Amit

AU - González-Martí, Antonio

AU - Aghajanian, Carol

AU - Bradley, William

AU - Mathews, Cara

AU - Liu, Joyce

AU - McNamara, John

AU - Lowe, Elizabeth S.

AU - Ah-See, Mei Lin

AU - Moore, Kathleen N.

PY - 2023/1/1

Y1 - 2023/1/1

UR - https://www.scopus.com/pages/publications/85146237174

U2 - 10.1097/OGX.0000000000001120

DO - 10.1097/OGX.0000000000001120

M3 - Comment/debate

C2 - 36082969

AN - SCOPUS:85146237174

SN - 0029-7828

VL - 78

SP - 25

EP - 27

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 1

ER -

Overall Survival with Maintenance Olaparib at a 7-Year Follow-up in Patients with Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

UN SDGs

Access to Document

Other files and links

Cite this